Spero Therapeutics
SPRO
#9398
Rank
โ‚ฌ49.86 M
Marketcap
0,91ย โ‚ฌ
Share price
-4.30%
Change (1 day)
-25.30%
Change (1 year)

Spero Therapeutics (SPRO) Fails to deliver data

Key failure to deliver metrics for Spero Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spero Therapeutics (SPRO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Spero Therapeutics (SPRO) - since 2017

Volume in USD (price x number of shares), data since 2017

Spero Therapeutics (SPRO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ0.45 M-46.4%
2023โ‚ฌ0.85 M-88.65%
2022โ‚ฌ7.55 M81.02%
2021โ‚ฌ4.17 M23.57%
2020โ‚ฌ3.37 M2331.08%
2019โ‚ฌ0.13 M-93.38%
2018โ‚ฌ2.09 M-76.81%
2017โ‚ฌ9.04 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ0.05 Mโ‚ฌ0.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ82.46 Mโ‚ฌ0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.78 Mโ‚ฌ0.17 B๐Ÿ‡จ๐Ÿ‡ฆ Canada